Patients with brain metastases from gastrointestinal cancers show worse survival after stereotactic radiosurgery than those ...

Although cancer of the appendix is rare — typically, it's estimated to affect about 1 or 2 people for every 1 million in the ...

Gen X and millennials three times more likely to be diagnosed with appendix cancer than their parents, study finds - Cancer ...

Several cancers are becoming more common in young adults, including testicular cancer, melanoma, and cervical cancer. Blood-related cancers like B-cell lymphomas and plasma cell neoplasms are also on ...

We’ve all had those days when our stomachs feel a little off, maybe it’s a bit of bloating, or that all-too-familiar feeling ...

More people under 50 are getting appendix cancer. Here's what to know about this type of cancer, as well as why case rates ...

Marwan G. Fakih, MD, discusses topics in metastatic colorectal cancer from the Case-Based Roundtable meeting he moderated.

The increase in appendix cancer among younger adults is part of a broader trend seen in other gastrointestinal cancers, such ...

Experts worry about the uptick in cases as more Gen Xers and millennials are being diagnosed with a variety of ...

The FDA has approved a revised label for Merck’s immunotherapy drug Keytruda, limiting its use in some gastrointestinal cancer treatments to patients whose tumors express a minimum level of PD-L1 ...

A recent trial reveals that durvalumab enhances event-free survival in patients with resectable gastric and gastroesophageal junction adenocarcinoma.